Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.
To accelerate progress in the development of therapeutics for protozoan parasitic diseases, we are studying enzymes active in co- and post-translational protein modification that are already the focus of drug development in other eukaryotic systems. Inhibitors of the protein farnesyltransferases (PF...
Main Authors: | Gelb, M, Van Voorhis, W, Buckner, F, Yokoyama, K, Eastman, R, Carpenter, E, Panethymitaki, C, Brown, K, Smith, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2003
|
Similar Items
-
PIGGY BACK SEPARATOR DESIGN
by: Néhémie Bikayi Tshiani, et al.
Published: (2023-06-01) -
Use of Farnesyl Transferase Inhibitors in an Ageing Model in <i>Drosophila</i>
by: Annely Brandt, et al.
Published: (2023-10-01) -
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas
by: Linda Kessler, et al.
Published: (2021-10-01) -
Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy
by: Hahn, S, et al.
Published: (2000) -
Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor status.
by: Cornelissen, B, et al.
Published: (2004)